The Quantum Computing Paradox: Why Patient Investors Should Look Beyond Rigetti

The quantum computing revolution promises infinite possibilities, yet investment opportunities in this space present a curious challenge: the companies pursuing it most aggressively may require you to wait the longest before knowing if they can actually succeed.

Consider Rigetti Computing, a high-profile player in quantum research. The company faces a critical test in early March, with Q4 earnings revealing whether recent revenue challenges have materialized into missed targets. But even if Rigetti clears this particular hurdle, a much larger problem looms ahead.

The Technical and Financial Reality Check

For a quantum computer to become commercially viable, industry experts estimate it needs at least 1 million physical qubits with 99.99% two-qubit gate fidelity—potentially even 99.99999% accuracy. Rigetti currently operates with fewer than 1,000 qubits and doesn’t meet even basic accuracy thresholds. The company likely needs half a decade or more just to approach the minimum viability threshold, meaning investors face an extraordinarily long uncertainty window.

The financial picture compounds this problem. Rigetti burns through approximately $350 million annually, with losses accelerating every year over the past five years. Analyst consensus suggests the company won’t turn profitable until at least 2030, if ever. With $450 million in cash reserves and only $150 million projected to burn through 2028, Rigetti can survive the waiting period—but survival doesn’t equal success.

The IBM Alternative: Maturity Meets Innovation

A fundamentally different path exists in the quantum space: International Business Machines (IBM). While IBM has researched quantum computing as long as Rigetti, it’s already accumulated over $1 billion in orders for quantum testing, trials, and exploratory work. This vastly exceeds Rigetti’s $7.5 million in annual revenue.

IBM’s quantum strategy centers on developing a “fault-tolerant” quantum computer with commercial viability expected by 2029. But here’s the critical difference: IBM already operates a massively profitable business. The company generated $10.6 billion in profit over the past year while producing $11.6 billion in free cash flow. Earnings are growing north of 7% annually despite the diversified business model.

From a valuation perspective, IBM trades at 22.6 times trailing earnings with a price-to-free-cash-flow ratio of just 20.6. The company also pays a 2.6% dividend yield—generating real returns while shareholders wait for quantum breakthroughs to materialize.

The Infinite Timeline Problem and Patient Capital

The quantum computing industry operates on an infinite timeline in many respects—neither Rigetti nor IBM will deliver mainstream quantum solutions overnight. Yet this reality creates a paradox for investors.

Betting on Rigetti means accepting years of uncertainty about basic commercial viability, funded by dwindling cash reserves and perpetual losses. It’s a speculative position requiring extraordinary patience and tolerance for potential total loss.

IBM’s approach offers a more balanced risk profile. The company generates substantial profits and cash flow today while building tomorrow’s quantum capabilities. Investors receive current income through dividends and earnings growth while maintaining exposure to quantum computing’s eventual breakthrough moment.

When the Motley Fool Stock Advisor team identifies their highest-conviction investment ideas, they focus on companies that don’t require believers to make infinite leaps of faith. Historical picks like Netflix (recommended December 2004) and Nvidia (recommended April 2005) delivered extraordinary returns precisely because they combined near-term business viability with long-term growth potential. Netflix investors didn’t need to wait indefinitely for the streaming concept to work—it was already working. The question was merely how big it could become.

Rigetti remains years away from proving its core concept works at commercial scale. IBM, by contrast, has already proven its business while advancing quantum research. For investors with limited patience—or capital—to wait an infinite timeline, the choice becomes clearer.